載入...
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs
BACKGROUND: High altitude illness (HAI) is a term used to describe a group of mainly cerebral and pulmonary syndromes that can occur during travel to elevations above 2500 metres (˜ 8200 feet). Acute mountain sickness (AMS), high altitude cerebral oedema (HACE) and high altitude pulmonary oedema (HA...
Na minha lista:
| 發表在: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Ltd
2018
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494375/ https://ncbi.nlm.nih.gov/pubmed/29529715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012983 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|